Primary Brain Tumor Clinical Trial
Official title:
Assessment of the Presence of Symptoms of End-of-life Discomfort and Their Management in Children With a Primary Brain Tumor in the Grand Est Region. Impact of the Development of Pediatric Palliative Care
Despite medical advances, cancer remains the leading cause of death by disease in children. Brain tumors are the second most common cause of cancer in children after leukemia, representing 25% of pediatric cancers. The overall survival rate is about 50% with extremes ranging from less than 5% to more than 90% depending on the histological type of brain tumor. The end of life of children with a brain tumor is marked by the possibility of discomfort symptoms, painful or not, and by a progressive neurological deterioration, which makes the management of these children complex for both families and health professionals. Over the last decade, the concept of palliative care has been increasingly integrated into pediatric onco-hematology services with the primary objective of better symptom control in a global approach to the child and his or her family in order to aim at a better quality of life.
The main objective of the study is to compare the occurrence and management of end-of-life symptoms in children who died of a primary brain tumor over 2 periods, in 2009 - 2010 and in 2019 - 2020, followed in the Pediatric Oncology departments of Strasbourg, Besançon, Dijon, Nancy and Reims. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05539677 -
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
|
||
| Recruiting |
NCT04066465 -
Neurocognitive Function After Proton Therapy in Children and Adolescents
|
||
| Completed |
NCT02392078 -
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
|
||
| Not yet recruiting |
NCT02272452 -
Assistance in Neurosurgery (ExtempoRMN)
|
N/A | |
| Recruiting |
NCT06104488 -
A Study of Avutometinib for People With Solid Tumor Cancers
|
Phase 1 | |
| Completed |
NCT02338037 -
Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors
|
Early Phase 1 | |
| Completed |
NCT05328739 -
The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers
|
N/A | |
| Completed |
NCT02034708 -
Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors
|
Phase 4 | |
| Terminated |
NCT00629395 -
Computerized Cognitive Training for Childhood Cancer Survivors
|
N/A | |
| Completed |
NCT04919993 -
CBT for Insomnia in Primary Brain Tumor Patients
|
N/A | |
| Completed |
NCT04075370 -
Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer
|
||
| Completed |
NCT01242566 -
Temozolomide in Elderly Patients With KPS < 70
|
Phase 2 | |
| Not yet recruiting |
NCT06439420 -
CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
|
Phase 2 | |
| Recruiting |
NCT01535430 -
Assessment of Eloquent Function in Brain Tumor Patients
|
||
| Completed |
NCT00285324 -
Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis
|
N/A | |
| Recruiting |
NCT03684109 -
Non-invasive Glioma Characterization Through Molecular Imaging
|
N/A | |
| Recruiting |
NCT05576103 -
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
|
||
| Not yet recruiting |
NCT00265174 -
Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer.
|
N/A | |
| Recruiting |
NCT05106296 -
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
|
Phase 1 | |
| Completed |
NCT04118426 -
Cognitive Function After Radiation Therapy for Brain Tumours
|